# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

B-Cell Lymphomas

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 21-30 of 573 results.
Study of A-319 in Patients With Relapsed or Refractory B-cell Lymphoma
Status: Not yet recruiting
Last Changed: Aug 14, 2019
First Received: Aug 14, 2019
Disease(s): Relapsed or Refractory B-cell Lymphoma
Intervention(s): Recombinant Anti-CD19m-CD3 Antibody Injection
Design of New Personalized Therapeutic Approaches for Diffuse Large B-cell Lymphoma
Status: Recruiting
Last Changed: Apr 16, 2019
First Received: Jan 09, 2019
Disease(s): Diffuse Large B Cell Lymphoma
Intervention(s): Gut microbiota samples
Locations: Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Meldola, FC, Italy
Institute Of Hematology "Seràgnoli", Bologna, Italy
Mature B-Cell Lymphoma And Leukemia Study III
Status: Recruiting
Last Changed: Jul 18, 2019
First Received: Jan 12, 2010
Disease(s): Mature B-Cell Lymphoma
Intervention(s): COPAD, COP, COPD M3, CYM, COP, COPADM8, CYVE
Locations: Rady Children's Hospital San Diego, San Diego, California, United States
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Children's Cancer Hospital, Cairo, Egypt
National University Health System, Singapore, Singapore
CTA101 in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
Status: Not yet recruiting
Last Changed: Oct 31, 2019
First Received: Jul 19, 2019
Disease(s): Diffuse Large B-cell Lymphoma
Intervention(s): CTA101
Locations: the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Early Systemic Central Nervous System Prophylaxis in Diffuse Large B-cell Lymphoma
Status: Not yet recruiting
Last Changed: Apr 09, 2019
First Received: Oct 25, 2018
Disease(s): Diffuse Large B Cell Lymphoma
Intervention(s): Methotrexate, Cytarabine
Locations: Helena Lau, Providence, Rhode Island, United States
Safety and Efficacy of iPD1 CD19 eCAR T Cells in Relapsed or Refractory B-cell Lymphoma
Status: Recruiting
Last Changed: Sep 14, 2017
First Received: Jul 05, 2017
Disease(s): Relapsed or Refractory B-cell Lymphoma
Intervention(s): iPD1 CD19 eCAR T cells, Fludarabine and cyclophosphamide
Locations: Beijing Cancer Hosptical, Beijing, China
Trial of Idelalisib in Patients With Relapsed Diffuse Large B-cell Lymphoma
Status: Recruiting
Last Changed: Jul 10, 2019
First Received: Jul 03, 2018
Disease(s): Diffuse Large B Cell Lymphoma
Intervention(s): Idelalisib
Locations: Aarhus University Hospital, Aarhus C, Denmark
Odense University Hospital, Odense, Denmark
Halmstad County Hospital, Halmstad, Sweden
Linkoping University Hospital, Linköping, Sweden
Skane University Hospital, Lund, Sweden
... and 2 other locations.
A Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma Patients
Status: Not yet recruiting
Last Changed: Aug 29, 2018
First Received: Aug 29, 2018
Disease(s): Diffuse Large B-Cell Lymphoma, Unspecified Site
Intervention(s): G-CHOP, R-CHOP
Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma
Status: Recruiting
Last Changed: Nov 08, 2019
First Received: Sep 24, 2018
Disease(s): Diffuse Large B Cell Lymphoma
Intervention(s): Radiation Therapy
Locations: Dana Farber Cancer Institute, Boston, Massachusetts, United States
Mayo Clinic, Rochester, Minnesota, United States
Duke University Medical Center, Durham, North Carolina, United States
Juntendo University, Tokyo, Japan
Yonsei University Health System, Seoul, Korea, Republic of
... and 2 other locations.
Real Time Molecular Characterization of Diffuse Large B Cell Lymphoma (DLBCL)
Status: Recruiting
Last Changed: Mar 13, 2019
First Received: Apr 07, 2017
Disease(s): Diffuse Large B Cell Lymphoma
Intervention(s): Biological samples collection
Locations: CHU Caen, Caen, France
Hopital Henri Mondor, Creteil, France
CHU Le Bocage, Dijon, France
CH Départemental, La Roche sur Yon, France
CHU Claude Hurriez, Lille, France
... and 11 other locations.